Search results
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 6 days agoModerna has announced that its Phase III clinical trial of the investigational next-generation...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 5 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Moderna Stock (NASDAQ:MRNA): Is There Life Beyond Disease Outbreaks?
TipRanks via Yahoo Finance· 2 days agoModerna (NASDAQ:MRNA) stock has surged 40.8% since the turn of the year. Some of this momentum can...
Moderna says next-gen COVID shot effective in study
BioPharma Dive via Yahoo Finance· 7 days agoTrial data suggest the shot — an important component of an upcoming combination inoculation — has proven at least as effective, and in some cases...
Moderna Just Gave Investors Another Reason to Buy the Stock | The Motley Fool
The Motley Fool· 4 days agoModerna (MRNA -3.58%) is best known for its work in the coronavirus vaccine market. Let's look...
Gateway - Quartz
Quartz· 1 day agoModerna stock jumped 7% during premarket trading on Thursday after the pharma company, known for its mRNA COVID-19 vaccine, reported a profit of $217 million in its fourth ...
Moderna (NASDAQ:MRNA) shareholders are still up 857% over 5 years despite pulling back 6.1% in the...
Simply Wall St. via Yahoo Finance· 6 days agoLong term investing can be life changing when you buy and hold the truly great businesses. And...
Moderna stock is lone omen of bird flu pandemic
Reuters· 2 days agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
Moderna (NASDAQ:MRNA) Stock Price Down 2.2% on Insider Selling
ETF DAILY NEWS· 6 days agoShares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) traded down 2.2% during mid-day trading on Wednesday following insider selling activity. 392,597 shares changed hands ...
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 2 days agoModerna (MRNA) ended the recent trading session at $137.90, demonstrating a -1.52% swing from the...